[1] Tian XT, Xu YJ, Yang YQ. Gender differences in arrhythmias:
focused on atrial fibrillation[J]. J Cardiovasc Transl Res, 2020,
13(1):85-96.
[2] Huang X, Li Y, Zhang J, et al. The molecular genetic basis of
atrial fibrillation[J]. Hum Genet, 2020, 139 (12):1485-1498.
[3] Kim JA, Chelu MG, Li N. Genetics of atrial fibrillation[J].
Curr Opin Cardiol, 2021, 36(3):281-287.
[4] Roselli C, Rienstra M, Ellinor PT. Genetics of atrial fibrillation
in 2020: GWAS, genome sequencing, polygenic risk, and
beyond[J]. Circ Res, 2020, 127(1):21-33.
[5] Ragab AAY, Sitorus GDS, Brundel BBJJM, et al. The genetic
puzzle of familial atrial fibrillation[J]. Front Cardiovasc Med,
2020, 7:14.
[6] January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/
HRS guideline for the management of patients with atrial
fibrillation: a report of the American College of Cardiology/
American Heart Association Task Force on practice guidelines
and the Heart Rhythm Society[J]. Circulation, 2014,
130(23):e199-e267.
[7] 乔祺, 杨晨曦, 顾佳宁, 等. 散发性扩张型心肌病相关ISL1基
因突变分析[J]. 国际心血管病杂志, 2020, 47(3):162-167.
[8] 乔祺, 杨晨曦, 顾佳宁, 等. KLF15基因突变导致心房颤动的
机制研究[J]. 国际心血管病杂志, 2021, 48(1):53-57.
[9] Guo XJ, Qiu XB, Wang J, et al. PRRX1 loss-of-function
mutations underlying familial atrial fibrillation[J]. J Am Heart
Assoc, 2021, 10(24):e023517.
[10] Bergwerff M, Gittenberger-de Groot AC, DeRuiter MC, et al.
Patterns of paired-related homeobox genes PRX1 and PRX2
suggest involvement in matrix modulation in the developing
chick vascular system[J]. Dev Dyn, 1998, 213(1):59-70.
[11] Leussink B, Brouwer A, el Khattabi M, et al. Expression
patterns of the paired-related homeobox genes MHox/Prx1
and S8/Prx2 suggest roles in development of the heart and the
forebrain[J]. Mech Dev, 1995, 52(1):51-64.
[12] Chesterman ES, Kern MJ. Comparative analysis of Prx1 and
Prx2 expression in mice provides evidence for incomplete
compensation[J]. Anat Rec, 2002, 266(1):1-4.
[13] Ha?ssaguerre M, Ja?s P, Shah DC, et al. Spontaneous initiation
of atrial fibrillation by ectopic beats originating in the
pulmonary veins[J]. N Engl J Med, 1998, 339(10):659-666.
[14] Oca?a OH, Córcoles R, Fabra A, et al. Metastatic colonization
requires the repression of the epithelial-mesenchymal
transition inducer Prrx1[J]. Cancer Cell, 2012, 22(6):709-724.
[15] Bergwerff M, Gittenberger-de Groot AC, Wisse LJ, et al.
Loss of function of the Prx1 and Prx2 homeobox genes
alters architecture of the great elastic arteries and ductus
arteriosus[J]. Virchows Arch, 2000, 436(1):12-19.
[16] Blaschke RJ, Hahurij ND, Kuijper S, et al. Targeted mutation
reveals essential functions of the homeodomain transcription
factor Shox2 in sinoatrial and pacemaking development[J].
Circulation, 2007, 115(14):1830-1838.
[17] Liang X, Zhang Q, Cattaneo P, et al. Transcription factor ISL1
is essential for pacemaker development and function[J]. J Clin
Invest, 2015, 125(8):3256-3268.
[18] Li N, Wang ZS, Wang XH, et al. A SHOX2 loss-of-function
mutation underlying familial atrial fibrillation[J]. Int J Med
Sci, 2018, 15(13):1564-1572.
[19] Wu SH, Wang XH, Xu YJ, et al. ISL1 loss-of-function
variation causes familial atrial fibrillation[J]. Eur J Med Genet,
2020, 63(11):104029.
[20] Tucker NR, Dolmatova EV, Lin H, et al. Diminished PRRX1
expression is associated with increased risk of atrial fibrillation
and shortening of the cardiac action potential[J]. Circ
Cardiovasc Genet, 2017, 10(5):e001902.